Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 11:16AM ET
5.84
Dollar change
+0.14
Percentage change
2.46
%
IndexRUT P/E- EPS (ttm)-0.36 Insider Own3.23% Shs Outstand39.61M Perf Week5.80%
Market Cap232.78M Forward P/E- EPS next Y-0.37 Insider Trans0.00% Shs Float38.57M Perf Month1.92%
Income-14.12M PEG- EPS next Q-0.14 Inst Own89.80% Short Float6.37% Perf Quarter-27.36%
Sales329.54M P/S0.71 EPS this Y-620.83% Inst Trans-0.27% Short Ratio4.85 Perf Half Y-19.34%
Book/sh9.97 P/B0.59 EPS next Y15.03% ROA-2.67% Short Interest2.46M Perf Year-52.90%
Cash/sh1.53 P/C3.82 EPS next 5Y15.00% ROE-3.49% 52W Range5.26 - 12.62 Perf YTD-25.51%
Dividend Est.- P/FCF- EPS past 5Y- ROI-3.50% 52W High-53.72% Beta0.66
Dividend TTM- Quick Ratio1.55 Sales past 5Y5.40% Gross Margin45.78% 52W Low11.03% ATR (14)0.23
Dividend Ex-Date- Current Ratio2.38 EPS Y/Y TTM57.64% Oper. Margin-7.34% RSI (14)56.27 Volatility4.04% 4.41%
Employees815 Debt/Eq0.01 Sales Y/Y TTM0.49% Profit Margin-4.28% Recom1.75 Target Price14.00
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-236.06% Payout- Rel Volume0.53 Prev Close5.70
Sales Surprise-2.57% EPS Surprise32.16% Sales Q/Q-7.44% EarningsApr 04 BMO Avg Volume506.73K Price5.84
SMA205.97% SMA500.70% SMA200-20.50% Trades Volume82,248 Change2.46%
Date Action Analyst Rating Change Price Target Change
Sep-25-23Initiated H.C. Wainwright Buy $19
Apr-17-23Downgrade Raymond James Strong Buy → Outperform $14 → $13
Oct-15-21Upgrade Canaccord Genuity Hold → Buy $28 → $37
Aug-20-21Initiated Oppenheimer Perform
Nov-25-20Upgrade Raymond James Mkt Perform → Strong Buy $18
Apr-08-20Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Apr-01-19Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Apr-03-18Upgrade Raymond James Mkt Perform → Outperform
Jan-05-18Downgrade Craig Hallum Buy → Hold
Apr-07-17Reiterated Cantor Fitzgerald Overweight $20 → $21
Mar-19-24 04:01PM
Mar-15-24 06:15PM
Mar-08-24 06:15PM
Mar-06-24 04:01PM
Mar-01-24 06:15PM
06:15PM Loading…
Feb-22-24 06:15PM
Feb-16-24 10:57AM
Feb-15-24 06:15PM
04:05PM
Feb-09-24 06:15PM
Jan-25-24 10:35AM
Jan-23-24 08:00AM
Jan-08-24 10:17AM
08:29AM
Jan-06-24 12:25AM
03:35PM Loading…
Jan-05-24 03:35PM
02:13PM
12:51PM
12:20PM
08:10AM
07:24AM
07:09AM
07:00AM
Dec-29-23 10:00AM
Dec-21-23 04:01PM
Dec-19-23 06:15PM
Dec-11-23 06:15PM
Dec-07-23 04:01PM
08:00AM
Dec-04-23 06:15PM
06:15PM Loading…
Nov-28-23 06:15PM
Nov-22-23 06:15PM
Nov-16-23 06:15PM
Nov-10-23 06:15PM
Oct-06-23 09:00AM
Oct-05-23 10:45AM
08:18AM
Oct-04-23 11:51PM
06:15PM
12:24PM
08:15AM
07:13AM
07:00AM
Sep-27-23 10:00AM
Sep-25-23 01:21PM
Sep-12-23 04:01PM
Sep-07-23 06:15PM
Sep-01-23 06:51PM
Aug-29-23 06:15PM
Aug-23-23 06:15PM
Aug-17-23 06:15PM
Aug-16-23 11:08AM
Aug-15-23 04:01PM
Aug-11-23 06:15PM
Aug-03-23 08:00AM
Jul-31-23 04:01PM
Jul-25-23 09:53AM
Jul-24-23 04:01PM
Jul-14-23 12:07AM
Jul-13-23 11:59AM
12:12AM
Jul-12-23 10:29AM
08:25AM
07:22AM
07:00AM
Jul-11-23 11:52AM
Jul-05-23 10:00AM
Jul-03-23 12:20PM
Jun-21-23 08:00PM
10:09AM
Jun-20-23 04:01PM
Jun-09-23 02:56PM
Jun-08-23 04:01PM
May-18-23 07:39AM
May-16-23 09:12AM
May-15-23 09:41AM
08:59AM
Apr-26-23 08:00PM
Apr-17-23 08:29AM
Apr-14-23 09:17AM
Apr-11-23 04:01PM
Apr-10-23 08:30AM
Apr-04-23 09:53AM
Apr-01-23 12:09PM
Mar-31-23 07:38PM
Mar-30-23 08:15AM
07:00AM
Mar-18-23 09:02AM
Mar-13-23 04:01PM
Feb-28-23 08:00AM
Jan-24-23 12:43PM
Jan-19-23 10:23AM
Jan-10-23 07:28AM
Jan-09-23 05:12AM
Jan-06-23 09:03AM
Jan-05-23 05:27PM
08:15AM
07:00AM
Dec-30-22 11:33AM
10:15AM
AngioDynamics, Inc. operates as a medical device company, which engages in the development, manufacturing and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It operates through the Med Tech and Med Device segments. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Trowbridge Stephen AEVP and CFOJul 19 '23Option Exercise0.008,7690123,364Jul 26 09:32 PM
Centea ScottSVP/GM, VITJul 19 '23Option Exercise0.003,415061,543Jul 26 09:32 PM
Campbell Chad ThomasSVP/GM, Vascular AccessJul 19 '23Option Exercise0.003,900051,409Jul 26 09:32 PM
Helsel DaveSVP Global Operations and R&DJul 19 '23Option Exercise0.004,371032,660Jul 26 09:32 PM
Clemmer James CPresident and CEOJul 19 '23Option Exercise0.0031,5720560,638Jul 26 09:32 PM